Peripheral arterioportal fistula: Demonstration with contrast-enhanced sonography

Journal of Ultrasound in Medicine

Volumn 24, Issue 7, 2005, Pages 1027-1030

  Catalano, Orlando ^a   Siani, Alfredo ^a  

^a Instituto Pascale   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ABLATION; BIOLOGICAL ORGANS; DIAGNOSIS; ETHANOL; FREQUENCIES;

CONTRAST-ENHANCED SONOGRAPHY (CES); FISTULA; LIVER; OPACIFICATION;

ULTRASONICS;

ALCOHOL;

AGED; ANAMNESIS; ARTICLE; BLOOD VESSEL FISTULA; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; FOLLOW UP; HUMAN; INJECTION; LABORATORY DIAGNOSIS; LIVER CELL CARCINOMA; MALE; PERIPHERAL ARTERIOPORTAL FISTULA; RADIODIAGNOSIS; RECURRENT DISEASE;

EID: 21244505044     PISSN: 02784297     EISSN: None     Source Type: Journal    
DOI: 10.7863/jum.2005.24.7.1027     Document Type: Article

References (15)

1. Catalano O, Lobianco R, Cusati B, Siani A. Hepatocellular carcinoma: spectrum of contrast-enhanced gray-scale harmonic sonography findings. Abdom Imaging 2004; 29:341-347.
2. Ding H, Kudo M, Onda H, Suetomi Y, Minami Y, Maekawa K. Contrast-enhanced subtraction harmonic US for evaluating treatment response in patients with hepatocellular carcinoma. AJR Am J Roentgenol 2001; 176:661-666.
3. Ding H, Kudo M, Onda H, et al. Evaluation of posttreatment response of hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: comparison with dynamic CT. Radiology 2001; 221:721-730.
4. Esteban JM, Gil J. Therapeutic effect of chemoembolization therapy on hepatocellular carcinoma: evaluation with contrast-enhanced harmonic imaging. Acad Radiol 2002; 9(suppl 2):S382-S383.
5. Wen YL, Kudo M, Zheng RQ, et al. Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phase-inversion harmonic US. AJR Am J Roentgenol 2003; 181:57-63.
6. Catalano O, Esposito M, Nunziata A, Siani A. Multiphase helical CT findings after percutaneous ablation procedures for hepatocellular carcinoma. Abdom Imaging 2000; 25:607-614.
7. Itai Y, Hachiya J, Makita K, Ohtomo K, Kokubo T, Yamauchi T. Transient hepatic attenuation differences on dynamic computed tomography, J Comput Assist Tomogr 1987; 11:461-465.
8. Park CM, Cha SH, Kim DH, et al. Hepatic arterioportal shunts not directly related to hepatocellular carcinoma: findings on CT during hepatic arteriography, CT arterial portography and dual phase spiral CT. Clin Radiol 2000; 55:465-470.
9. Quiroga S, Sebastia MC, Moreiras M, Pallisa E, Rius JM, Alvarez-Castells A. Intrahepatic arterioportal shunt: helical CT findings. Eur Radiol 1999; 9: 1126-1230.
10. Fujita T, Honjo K, Ito K, et al. Dynamic MR follow-up of small hepatocellular carcinoma after percutaneous ethanol injection therapy. J Comput Assist Tomogr 1998; 22:379-386.
11. Bolognesi M, Sacerdoti D, Bombonato G, Chiesura-Corona M, Merkel C, Gatta A. Arterioportal fistulas in patients with liver cirrhosis: usefulness of color Doppler US for screening. Radiology 2000; 216: 738-743.
12. Lafortune M, Breton G, Charlebois S. Arterioportal fistula demonstrated by pulsed Doppler ultrasonography. J Ultrasound Med 1986; 5:105-106.
13. Catalano O, Cusati B, Sandomenico F, Nunziata A, Siani A. Helical CT findings in patients with hepatocellular carcinoma treated with percutaneous ablation procedures. J Comput Assist Tomogr 2000; 24: 748-754.
14. Lee WK, Stuckey S. Arterioportal fistula following liver biopsy demonstrated by lipiodol computed tomography. Clin Radiol 2000; 55:489-491.
15. Huang MS, Lin Q, Jiang ZB, et al. Comparison of long-term effects between intra-arterially delivered ethanol and Gelfoam for the treatment of severe arterioportal shunt in patients with hepatocellular carcinoma. World J Gastroenterol 2004; 10:825-829.